Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 AI for Real-Time Monitoring and Remote Care (AI-powered wearables and telemedicine) Showcase will provide a 15-30 minute time slot for selected companies to explore the transformative role of artificial intelligence in accelerating the discovery, development, and optimization of novel therapeutic modalities. From predictive algorithms for drug efficacy to real-time analysis in clinical trials, AI is revolutionizing the way we approach emerging therapies, including RNA-based treatments, gene editing, and personalized medicine. Industry leaders and experts will discuss AI-driven advancements, collaborative frameworks, and the challenges of integrating cutting-edge technologies into therapeutic innovation. Join us for an in-depth look at how AI is shaping the future of breakthrough therapeutics.
Confirmed Presenting Companies:
Speaker Profile
Ph.D., CEO, NeuroSentry
Biography
Dr. Rohit Jain is the Co-Founder and Chief Executive Officer of NeuroSentry, where he leads the companys vision to bring real-time, precision stroke detection to clinical practice. An applied mathematician and data scientist by training, Dr. Jain brings deep expertise in computational modeling, machine learning, and biomedical signal processing. Before founding NeuroSentry, he served as Head of Data Science at UCSF, leading development of EEG analyticswithin the Departments of Neurology and Pediatrics, and previously held leadership roles at nference and NeuTrace, where he contributed to FDA-cleared cardiac electrophysiology systems. His work has resulted in multiple granted and published patents in medical device software, data visualization, and predictive analytics. Under his leadership, NeuroSentry is evolving from a research concept into a clinically validated platform with regulatory readiness and strong strategic partnerships, driving a future where brain data translates directly into life-saving clinical action.
Talk
NeuroSentry: EEG based Real-time stroke detection and monitoring
NeuroSentry is revolutionizing stroke detection for perioperative patients. In this talk we will discuss how NeuroSentry's flagship system enables continuous, automated analysis of brain activity, quantifying stroke onset and severity in real time throughintuitive visualizations and numeric trend outputs.
AI for Real-Time Monitoring and Remote Care Showcase:
NeuroSentry
NeuroSentry is a medical technology company advancing real-time stroke detection and monitoring through its proprietary EEG-based software platform.
Originating from the University of California, San Francisco (UCSF), NeuroSentry addresses one of the most critical gaps in neurological care: recognizing strokes in sedated or anesthetized patients, where traditional tools often fail.
